Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2026-01-01 @ 3:47 PM
Study NCT ID:
NCT00121056
Status:
COMPLETED
Last Update Posted:
2008-12-05
First Post:
2005-06-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations
Sponsor:
Amgen
Organization:
Study Overview
Official Title:
Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations (REKinDLE)
Status:
COMPLETED
Status Verified Date:
2008-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if Enbrel® or Kineret® will have a positive effect on subject functionality as measured by the Health Assessment Questionnaire Disability Index (HAQDI).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: